Gagnon Robert E. (CIK 1504983) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-11). Recent activity: Buy HBIO (16,556 shares), Sell IRD (7,842 shares), Buy IRD (400,000 shares), Sell VSTM (283 shares), Sell VSTM (281 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | HARVARD BIOSCIENCE INC (HBIO) | Director | Buy | 16,556 | $0 |
| 2026-04-27 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | Sell | 7,842 | $40,658 |
| 2026-01-26 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | Buy | 400,000 | $0 |
| 2025-12-18 | Verastem, Inc. (VSTM) | Director | Sell | 283 | $2,587 |
| 2025-09-18 | Verastem, Inc. (VSTM) | Director | Sell | 281 | $2,807 |
| 2025-09-11 | Opus Genetics, Inc. (IRD) | Chief Financial Officer | Buy | 200,000 | $0 |
| 2025-07-18 | HARVARD BIOSCIENCE INC (HBIO) | Director | Buy | 110,000 | $0 |
| 2025-06-20 | Verastem, Inc. (VSTM) | Director | Sell | 284 | $1,605 |
| 2025-05-27 | Verastem, Inc. (VSTM) | Director | Buy | 8,333 | $0 |
| 2025-03-19 | Verastem, Inc. (VSTM) | Director | Sell | 284 | $1,974 |
Source: SEC Form 4 filings · as of 2026-06-11